Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases - Elsevier eBook on VitalSource, 10th Edition
Elsevier eBook on VitalSource
-
- Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information
- Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, communication to the public about infectious diseases, and the effects of climate change on infectious diseases
- Provides up-to-date coverage of recent advances in the field: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as nucleic acid amplification and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV), and our relationship with the human microbiome
- Features more than 1,500 high-quality, full-color photographs―with many new to this edition
- Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from Bethesda, MD, as well as a new team of expert associate editors Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre—each a leading authority in their field
- Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America
- Includes regular updates online for the life of the edition
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
-
I Basic Principles in the Diagnosis and Management of Infectious Diseases
A Microbial Pathogenesis
1. A Molecular Perspective of Microbial Pathogenicity
2. The Human Microbiome
3. Prebiotics, Probiotics, and Synbiotics
B Host Defense Mechanisms
4. Innate (General or Nonspecific) Host Defense Mechanisms
5. Adaptive Immunity: Antibodies and Immunodeficiencies
6. Cell-Mediated Defense Against Infection
7. Mucosal Immunity
8. Granulocytic Phagocytes
9. Complement and Deficiencies
10. Human Genetics and Infection
11. Nutrition, Immunity, and Infection
12. Evaluation of the Patient With Suspected Immunodeficiency
C Epidemiology of Infectious Disease
13. Principles of Applied Epidemiology for the Practice of Infectious Diseases
14. Emerging and Reemerging Infectious Disease Threats
15. Bioterrorism: An Overview
D Clinical Microbiology
16. The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
E Anti-infective Therapy
17. Principles of Anti-infective Therapy
18. Molecular Mechanisms of Antibiotic Resistance in Bacteria
19. Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
20. Penicillins and β-Lactamase Inhibitors
21. Cephalosporins and Cephalosporin/ β-Lactamase Inhibitor Combinations
22. Carbapenems, Carbapenem/ β-Lactamase Inhibitor Combinations, and Aztreonam
23. Antibiotic Allergy
24. Aminoglycosides
25. Tetracyclines, Tetracycline Derivatives, and Chloramphenicol
26. Rifamycins
27. Metronidazole
28. Macrolides and Clindamycin
29. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
30. Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin)
31. Polymyxins (Polymyxin B and Colistin)
32. Linezolid, Tedizolid, and Other Oxazolidinones
33. Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
34. Quinolones
35. Antibiotics in Advanced Development and Other Agents
36. Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methenamine
37. Topical Antibacterials
38. Antimycobacterial Agents
39. Bacteriophage Therapy, Endolysin Therapy, and Antimicrobial Peptide Therapy
40. Antifungal Agents: Polyene Antifungals
41. Antifungal Drugs: Azole
42. Antifungal Drugs: Echinocandins and Other Beta-d-Glucan Inhibitors
43. Antifungal Drugs: Flucytosine
44. Antimalarial Drugs
45. Drugs for Protozoal Infections Other Than Malaria
46. Drugs for Helminths
47. Antiviral Agents: General Principles
48. Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2
49. Antivirals Against Herpesviruses
50. Antiviral Drugs Against Hepatitis Viruses
51. Miscellaneous Antiviral Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir)
52. Immunomodulators
53. Hyperbaric Oxygen
54. Antibiotic Stewardship
55. Designing and Interpreting Clinical Studies in Infectious Diseases
56. Outpatient Parenteral Antimicrobial Therapy
II Major Clinical Syndromes
A Fever
57. Temperature Regulation and the Pathogenesis of Fever
58. Fever of Unknown Origin
59. The Acutely Ill Patient With Fever and Rash
B Upper Respiratory Tract Infections
60. The Common Cold
61. Pharyngitis
62. Acute Laryngitis
63. Otitis Externa, Otitis Media, and Mastoiditis
64. Sinusitis
65. Epiglottitis
66. Infections of the Oral Cavity, Neck, and Head
C Pleuropulmonary and Bronchial Infections
67. Acute Bronchitis
68. Acute Exacerbations of Chronic Obstructive Pulmonary Disease
69. Acute Pneumonia
70. Pleural Effusion and Empyema
71. Bacterial Lung Abscess
72. Chronic Pneumonia
73. Cystic Fibrosis
D Urinary Tract Infections
74. Urinary Tract Infections
E Sepsis
75. Sepsis and Septic Shock
F Intraabdominal Infections
76. Peritonitis and Intraperitoneal Abscesses
77. Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
78. Pancreatic Infection
79. Splenic Abscess
80. Appendicitis
81. Diverticulitis and Neutropenic Enterocolitis
G Cardiovascular Infections
82. Endocarditis and Intravascular Infections
83. Prosthetic Valve Endocarditis
84. Infections of Nonvalvular Cardiovascular Devices
85. Prevention of Infective Endocarditis
86. Myocarditis and Pericarditis
87. Mediastinitis
H Central Nervous System Infections
88. Approach to the Patient With Central Nervous System Infection
89. Acute Meningitis
90. Chronic Meningitis
91. Encephalitis
92. Brain Abscess
93. Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
94. Cerebrospinal Fluid Shunt and Drain Infections
I Skin and Soft Tissue Infections
95. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
96. Myositis and Myonecrosis
97. Lymphadenitis and Lymphangitis
J Gastrointestinal Infections and Food Poisoning
98. Syndromes of Enteric Infection
99. Esophagitis
100. Diarrhea With Little or No Fever
101. Acute Dysentery Syndromes (Diarrhea With Fever)
102. Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
103. Foodborne Disease (Food Poisoning)
104. Tropical Sprue and Environmental Enteric Dysfunction
K Bone and Joint Infections
105. Infectious Arthritis of Native Joints
106. Osteomyelitis
107. Orthopedic Implant–Associated Infections
L Diseases of the Reproductive Organs and Sexually Transmitted Diseases
108. Anogenital Skin and Mucous Membrane Lesions
109. Urethritis
110. Vulvovaginitis and Cervicitis
111. Infections of the Female Pelvis
112. Prostatitis, Epididymitis, and Orchitis
M Eye Infections
113. Introduction to Eye Infections
114. Microbial Conjunctivitis
115. Microbial Keratitis
116. Endophthalmitis
117. Infectious Causes of Uveitis
118. Periocular Infections
N Hepatitis
119. Viral Hepatitis
O Acquired Immunodeficiency Syndrome
120. Human Immunodeficiency Viruses
121. Global Perspectives on Human Immunodeficiency Virus Infection and AIDS
122. Epidemiology and Prevention of AIDS and HIV Infection, Including Preexposure Prophylaxis and HIV Vaccine Development
123. Diagnosis of Human Immunodeficiency Virus Infection
124. The Immunology of HIV-1. Infection, Mechanisms of Viral Persistence, and Prospects for Cure
125. General Clinical Manifestations of Human Immunodeficiency Virus Infection
126. Pulmonary Manifestations of Human Immunodeficiency Virus Infection
127. Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of Human Immunodeficiency Virus Infection
128. Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1. and Opportunistic Infections
129. Pediatric Human Immunodeficiency Virus Infection
130. Antiretroviral Therapy for Human Immunodeficiency Virus Infection
131. Management of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
P COVID-19
132. Severe Acute Respiratory Syndrome Coronavirus 2. (SARS-CoV-2) Virology
133. Global Perspective and Epidemiology of COVID-19
134. Immunology and Diagnosis of SARS-CoV-2. and COVID-19
135. Clinical Manifestations of COVID-19. in Adults and Children
136. Treatment and Prevention of SARS-CoV-2. (COVID-19)
Q Miscellaneous Syndromes
137. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
III Infectious Diseases and Their Etiologic Agents
A Viral Diseases
138. Biology of Viruses and Viral Diseases
139. Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Mpox, and Cowpox
140. Other Poxviruses That Infect Humans: Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, and Yatapoxviruses
141. Introduction to Herpesviridae
142. Herpes Simplex Virus
143. Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
144. Cytomegalovirus
145. Epstein-Barr Virus (Infectious Mononucleosis, EBV-Associated Malignant Diseases, and Other Diseases)
146. Human Herpesvirus Types 6. and 7. (Exanthem Subitum)
147. Kaposi Sarcoma–Associated Herpesvirus (Human Herpesvirus 8)
148. Herpes B Virus
149. Adenoviruses
150. Papillomaviruses
151. JC, BK, and Other Polyomaviruses: Progressive Multifocal Leukoencephalopathy, BK Nephropathy, and Merkel Cell Carcinoma
152. Hepatitis B Virus
153. Hepatitis D Virus
154. Human Parvoviruses, Including Parvovirus B19, Human Bocaviruses, and Adeno-Associated Viruses (AAVs)
155. Orthoreoviruses and Orbiviruses
156. Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses
157. Rotaviruses
158. Alphaviruses
159. Rubella Virus (German Measles)
160. Flaviviruses
161. Hepatitis C
162. Coronaviruses, Including SARS and MERS
163. Parainfluenza Viruses
164. Mumps Virus
165. Respiratory Syncytial Virus
166. Human Metapneumovirus
167. Measles Virus (Rubeola)
168. Zoonotic Paramyxoviruses: Nipah, Hendra, and Pararubulaviruses
169. Vesicular Stomatitis Virus and Related Vesiculoviruses (Chandipura Virus)
170. Rabies (Rhabdoviruses)
171. Marburg and Ebola Virus Diseases
172. Influenza Viruses, Including Avian and Swine Influenza
173. Bunyavirus Infections: Hantavirus Syndromes, La Crosse Encephalitis, Rift Valley Fever, Crimean-Congo Hemorrhagic Fever, and Others
174. Lymphocytic Choriomeningitis Virus, Lassa Virus, Lujo Virus, and Other Hemorrhagic Fever Viruses (Arenaviruses)
175. Human T-Lymphotropic Virus
176. Introduction to Human Enteroviruses and Parechoviruses
177. Poliovirus
178. Coxsackieviruses, Echoviruses, and Other Enteroviruses (EV-D68, EV-D70, EV-A71)
179. The Human Parechoviruses
180. Hepatitis A Virus
181. Rhinovirus
182. Noroviruses and Sapoviruses (Caliciviruses)
183. Astroviruses and Picobirnaviruses
184. Hepatitis E Virus
B Prion Diseases
185. Prions and Prion Diseases of the CNS (Transmissible Neurodegenerative Diseases)
C Chlamydial Diseases
186. Chlamydia trachomatis
187. Psittacosis (Due to Chlamydia psittaci)
188. Chlamydia pneumoniae
D Mycoplasma Diseases
189. Mycoplasmoides (Mycoplasma) pneumoniae
190. Genital Mycoplasmas (Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma Species)
E Rickettsioses, Ehrlichioses, and Anaplasmoses
191. Introduction to Rickettsioses, Ehrlichioses, and Anaplasmoses
192. Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae
193. Coxiella burnetii (Q Fever)
194. Rickettsia prowazekii (Epidemic Typhus)
195. Rickettsia typhi (Murine Typhus)
196. Orientia tsutsugamushi (Scrub TYphus)
197. Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Other Anaplasmataceae
F Bacterial Diseases
198. Introduction to Bacteria and Bacterial Diseases
i. Infections Due to Gram-Positive Bacteria
199. Staphylococcus aureus
200. Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
201. Classification of Streptococci
202. Streptococcus pyogenes (Group A Streptococcus)
203. Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
204. Streptococcus pneumoniae
205. Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
206. Streptococcus agalactiae (Group B Streptococci)
207. Viridans Streptococci, Nutritionally Variant Streptococci, and Groups C and G Streptococci
208. Streptococcus anginosus Group
209. Corynebacterium diphtheriae (Diphtheria)
210. Other Coryneform Bacteria and Rhodococci
211. Listeria monocytogenes
212. Bacillus anthracis (Anthrax)
213. Bacillus Species and Related Genera Other Than Bacillus anthracis
214. Erysipelothrix rhusiopathiae
215. Whipple Disease
ii. Infections Due to Gram-Negative Bacteria
216. Neisseria meningitidis
217. Neisseria gonorrhoeae (Gonorrhea)
218. Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci
219. Vibrio cholerae
220. Other Pathogenic Vibrios
221. Campylobacter jejuni and Related Species
222. Helicobacter pylori and Other Gastric Helicobacter Species
223. Enterobacterales (Enterobacteriaceae)
224. Pseudomonas aeruginosa and Other Pseudomonas Species
225. Stenotrophomonas maltophilia and Burkholderia cepacia Complex
226. Burkholderia pseudomallei and Burkholderia mallei (Melioidosis, Glanders)
227. Acinetobacter Species
228. Salmonella Species
229. Bacillary Dysentery: Shigella and Enteroinvasive Escherichia coli
230. Haemophilus Species, Including H. influenzae and H. ducreyi (Chancroid)
231. Brucellosis (Brucella Species)
232. Francisella tularensis (Tularemia)
233. Pasteurella Species
234. Plague (Yersinia pestis)
235. Yersinia enterocolitica and Yersinia pseudotuberculosis
236. Bordetella pertussis
237. Rat-Bite Fever: Streptobacillus moniliformis and Spirillum minus
238. Legionnaires’ Disease and Pontiac Fever
239. Capnocytophaga Species
240. Bartonella, Including Cat-Scratch Disease
241. Klebsiella granulomatis (Donovanosis, Granuloma Inguinale)
242. Other Gram-Negative and Gram-Variable Bacilli
iii. Infections Due to Spirochetal Bacteria
243. Syphilis (Treponema pallidum)
244. Endemic Treponematoses
245. Leptospira Species (Leptospirosis)
246. Relapsing Fever Caused by Borrelia Species
247. Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi
iv. Infections Due to Anaerobic Bacteria
248. Anaerobic Infections: General Concepts
249. Clostridioides (Clostridium) difficile Infection
250. Tetanus (Clostridium tetani)
251. Botulism (Clostridium botulinum)
252. Diseases Caused by Clostridium
253. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)
254. Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli
v. Infections Due to Acid-Fast Organisms
255. Mycobacterium tuberculosis
256. Leprosy (Mycobacterium leprae)
257. Mycobacterium avium Complex
258. Infections Caused by Nontuberculous Mycobacteria Other Than Mycobacterium avium Complex
259. Nocardia Species
260. Agents of Actinomycosis
G Mycoses
261. Introduction to Mycoses
262. Candida Species
263. Aspergillus Species
264. Agents of Mucormycosis and Entomophthoramycosis
265. Sporothrix schenckii
266. Chromoblastomycosis
267. Mycetoma
268. Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)
269. Histoplasma capsulatum (Histoplasmosis)
270. Blastomyces
271. Coccidioides Species
272. Dermatophytosis (Ringworm) and Other Superficial Mycoses
273. Paracoccidioides
274. Uncommon Fungi and Related Species
275. Pneumocystis Species
276. Microsporidiosis
H Protozoal Diseases
277. Introduction to Protozoal Diseases
278. Entamoeba Species, Including Amebic Colitis and Liver Abscess
279. Free-Living Amebae
280. Malaria (Plasmodium Species)
281. Leishmania Species: Visceral, Cutaneous, and Mucosal Leishmaniasis
282. Trypanosoma Species (American Trypanosomiasis, Chagas Disease)
283. Agents of African Trypanosomiasis (Sleeping Sickness)
284. Toxoplasma gondii
285. Giardia lamblia
286. Trichomonas vaginalis
287. Babesia Species
288. Cryptosporidiosis (Cryptosporidium Species)
289. Cyclospora cayetanensis, Cystoisospora belli, Sarcocystis Species, Balantidium coli, and Blastocystis Species
I Diseases Due to Toxic Algae
290. Human Illness Associated With Cyanobacteria and Harmful Algal Blooms, Including Fish and Shellfish Poisoning Syndromes
J Diseases Due to Helminths
291. Introduction to Helminth Infections
292. Intestinal Nematodes (Roundworms)
293. Tissue Nematodes, Including Trichinellosis, Dracunculiasis, and the Filariases
294. Trematodes (Schistosomes and Liver, Intestinal, and Lung Flukes)
295. Tapeworms (Cestodes)
296. Visceral Larva Migrans and Other Uncommon Helminth Infections
K Ectoparasitic Diseases
297. Introduction to Ectoparasitic Diseases
298. Lice (Pediculosis)
299. Scabies
300. Myiasis and Tungiasis
301. Mites, Including Chiggers
302. Ticks, Including Tick Paralysis
L Diseases of Unknown Etiology
303. Kawasaki Disease
IV. Special Problems
A Nosocomial Infections
304. Infection Prevention and Control in Healthcare
305. Disinfection, Sterilization, and Hospital Waste
306. Infections Caused by Percutaneous Intravascular Devices
307. Nosocomial Pneumonia
308. Catheter-Associated Urinary Tract Infection (CAUTI) and CA-AB
309. Transfusion- and Transplant-Transmitted Infections
B Infections in Special Hosts
310. Infections in the Immunocompromised Host: Principles
311. Prophylaxis and Empirical Therapy in Cancer Patients
312. Infections in Hematopoietic Cell Transplantation
313. Infections in Solid Organ Transplant Recipients
314. Infections in Older Adults
315. Infections in Asplenic Patients
316. Infections in Persons Who Inject Drugs
C Surgical- and Trauma-Related Infections
317. Surgical Site Infections and Prophylaxis
318. Burns
319. Infections Following Trauma
320. Bites
D Immunization
321. Principles of Immunization for Public Health
322. Immunizations for Specific Infections
323. Protection of Travelers
324. Infections in Returning Travelers
E Emerging Issues in Infectious Diseases
325. Zoonoses
326. Communicating About Infectious Diseases to the Public
327. Basic Principles in Climate Change and Infectious Diseases -
-
Ways of Reading
- The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
- This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
- No information about nonvisual reading is available
-
Conformance
- No information is available
-
Navigation
- Table of contents to all chapters of the text via links
- Page list to go to pages from the print source version
-
Rich Content
- No information is available
-
Hazards
- No information is available
-
Product Content
- No information is available
-
Legal Considerations
- No information is available
-
Additional Accessibility Information
- Content is enhanced with ARIA roles to optimize organization and facilitate navigation
- Page breaks included from the original print source
- For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
- E-publication includes basic navigation (usually less detailed than TOC-based navigation)
- Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
- All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
- The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
-
Ways of Reading
as described in our 